Bladder Cancer Therapeutics Market Size, Share & Industry Analysis, By Drug (Pembrolizumab, Enfortumab Vedotin, Avelumab, Nivolumab, Erdafitinib, and Others), By Product Type (Cytotoxic Chemotherapy, Immune Checkpoint Inhibitors, Antibody-Drug Conjugates, FGFR Inhibitors, and Others), By Disease Stage (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer, and Others), By Therapy, By Route of Administration, By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, and Specialty Pharmacies), and Regional Forecast, 2026-2034